Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes

Diabetologia

Volumn 43, Issue 2, 2000, Pages 210-217

  Sohnlein P ^e   Muller M ^a   Syren, K ^a   Hartmann, U ^a   Bohm B O ^a   Meinck, H M ^e   Knip, M ^b   Akerblom, H K ^c   Richter, W ^d  

^a UNIVERSITY OF ULM   (Germany)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Stift Orthopadische U   (Germany)

^e NONE

Author keywords

Autoantibodies; Epitope specificity; Glutamate decarboxylase; Polyendocrine autoimmune syndrome; Prediabetes; Stiff man syndrome; Type I diabetes

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; PRIORITY JOURNAL; STIFF MAN SYNDROME;

EID: 1842475975     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050031     Document Type: Article

References (36)

1. 1. Riley WJ, Maclaren NK, Krischer et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167-1172
2. 2. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310
3. 3. Verge CF, Gianani R, Yu L et al. GS (1995) Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type 1 diabetes. Diabetes 44: 1176-1179
4. 4. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G (1989) Islet cell and other organ-specific autoantibodies in all children developing Type I (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387-395
5. 5. Schatz D, Krischer J, Horne G et al. (1994) Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerful as in unaffected relatives. J Clin Invest 93: 2403-2407
6. 6. Aanstoot HJ, Kang SM, Kim J et al. (1996) Identification and characterization of glima 38 a glycosylated islet cell membrane antigen which together with GAD65 and IA2 -marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97: 2772-2783
7. 7. Meinck HM, Ricker K, Huelser PJ, Schmid E, Pfeiffer J, Solimena M (1994) Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol 241: 157-166
8. 8. Solimena M, Folli F, Aparisi R, Pozza G, DeCamilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff man syndrome. N Engl J Med 322: 1555-1560
9. 9. Tuomi T, Bjorses P, Falorni A et al. (1996) Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 81: 1488-1494
10. 10. Betterle C, Presotto F, Magrin L et al. (1994) The natural history of pre-Type I (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases. Diabetologia 37: 95-103
11. 11. Bosi E, Becker F, Bonifacio E et al. (1991) Progression to type 1 diabetes in autoimmune endocrine patients with islet cell antibodies. Diabetes 40: 977-984
12. 12. Butler MH, Solimena M, Dirkx R Jr, Hayday A, De Camilli P (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178: 2097-2106
13. 13. Seissler J, Bieg S, Yassin N et al. (1994) Association between antibodies to the MR 67000 isoform of glutamate decarboxylase (GAD) and Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. Autoimmunity 19: 231-238
14. 14. Richter W, Jury KM, Loeffler D, Manfras BJ, Eiermann TH, Boehm BO (1995) Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus. Eur J Immunol 25: 1703-1712
15. 15. Baekkeskov S, Aanstoot HJ, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
16. 16. Ujihara N, Daw R, Gianani R, Boel E, Yu L, Powers AC (1994) Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 43 968-975
17. 17. Daw K, Powers AC (1995) Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes. Diabetes 44: 216-220
18. 18. Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in Stiff-Man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156: 818-825
19. 19. World Health Organization Study Group on Diabetes Mellitus (1985) Technical report series No 727, WHO, Geneva
20. 20. Skordis N, Maclaren N (1988) Immunogenetics of autoimmune polyglandular syndromes In: NR Farid (ed) Immunogenetics of endocrine disorders. Liss AR, New York, pp 373-399
21. 21. Gordon EE, Januszko DM, Kaufman L (1967) A critical survey of stiff-man syndrome. Am J Med 42: 582-599
22. 22. Kulmala P, Savola K, Peterson JS et al. (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population based study. J Clin Invest 101: 327-336
23. 23. Boehm BO, Manfras B, Seissler J et al. (1991) Epidemiology and immunogenetic background of islet cell antibody positive nondiabetic schoolchildren: the Ulm-Frankfurt population study. Diabetes 40: 1435-1459
24. 24. Wiest-Ladenburger UW, Hartmann R, Hartmann U, Berling K, Boehm BO, Richter W (1997) Combined analysis and single step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46: 565-571
25. 25. Richter W, Endl J, Eiermann TH et al. (1992) Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 89: 8467-8471
26. 26. Richter W, Mertens T, Schoel et al. (1994) Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 180: 721-726
27. 27. Syren K, Lindsay L, Stoehrer B et al. (1996) Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 157: 5208-5214
28. 28. Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1 IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Biochemistry 15: 429-436
29. 29. Mauch L, Seissler J, Haubruck H et al. (1993) Baculovirus-mediated expression of human 65 kDa and 67 kDa glutamic acid decarboxylase in Sf9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus. J Biochem 113: 699-704
30. 30. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
31. 31. Towbin H, Staehlin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets; procedure and some applications. Proc Natl Acad Sci USA 79: 4350-4354
32. 32. Schwartz H, Chandonia JM, Kash S et al. (1999) High resolution autoreactive epitope mapping and structural modeling of human glutamic acid decarboxylase (GAD65). Mol Cell Biol 287: 983-999
33. 33. Falorni A, Ackefors M, Carlberg C et al. (1996) Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 39: 1091-1098
34. 34. Tuomi T, Rowley MJ, Knowles WJ et al. (1994) Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin Immunol Immunopathol 71: 53-59
35. 35. Kim J, Namchuk M, Bugawan T et al. (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65 distinguish Stiff-Man-Syndrome from insulin-dependent diabetes mellitus. J Exp Med 180: 595-606
36. 36. Parish NM, Hutchings PR, O'Reilly L et al. (1995) Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models. Immunol Rev 144: 269-300